Trial intelligence / Profile preview

Levothyroxine Effects on Lipid Profile in Subclinical Hypothyroidism

IRCT138903244179N1Phase 4Completed

Sponsor
Kermanshah University of Medical Sciences
Start
May 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of levothyroxine sodium in hypothyroidism and dyslipidemia, sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Change in lipid profile. Started May 2010; status: completed.

02

Drugs

levothyroxine sodium
03

Conditions

hypothyroidismdyslipidemia

Beyond the preview

Go deeper on IRCT138903244179N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT138903244179N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call